Cargando…

Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases

INTRODUCTION: The optimal time to discontinue patients from mechanical ventilation is critical as premature discontinuation as well as delayed weaning can result in complications. The literature on diaphragm function assessment during the weaning process in the intriguing subpopulation of critically...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnakumar, Mathangi, Muthuchellappan, Radhakrishnan, Chakrabarti, Dhritiman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673684/
https://www.ncbi.nlm.nih.gov/pubmed/33210265
http://dx.doi.org/10.1007/s12028-020-01141-9
_version_ 1783611367025016832
author Krishnakumar, Mathangi
Muthuchellappan, Radhakrishnan
Chakrabarti, Dhritiman
author_facet Krishnakumar, Mathangi
Muthuchellappan, Radhakrishnan
Chakrabarti, Dhritiman
author_sort Krishnakumar, Mathangi
collection PubMed
description INTRODUCTION: The optimal time to discontinue patients from mechanical ventilation is critical as premature discontinuation as well as delayed weaning can result in complications. The literature on diaphragm function assessment during the weaning process in the intriguing subpopulation of critically ill neuromuscular disease patients is lacking. METHODS: Patients with neuromuscular diseases, on mechanical ventilation for more than 7 days, and who were ready for weaning were studied. During multiple T-piece trials over days, diaphragm function using ultrasound and diaphragm electrical activity (Edi peaks using NAVA catheter) was measured every 30 min till a successful 2 h weaning. RESULTS: A total of 18 patients were screened for eligibility over 5-month period and eight patients fulfilled the inclusion criteria. Sixty-three data points in these 8 subjects were available for analysis. A successful breathing trial was predicted by Edi reduction (1.22 μV for every 30 min increase in weaning duration; 0.69 μV for every day of weaning) and increase in diaphragm excursion (2.81 mm for every 30 min increase in weaning duration; 2.18 mm for every day of weaning). CONCLUSION: The Edi and diaphragm excursion changes can be used as additional objective tools in the decision-making of the weaning trials in neuromuscular disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12028-020-01141-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7673684
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-76736842020-11-19 Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases Krishnakumar, Mathangi Muthuchellappan, Radhakrishnan Chakrabarti, Dhritiman Neurocrit Care Original Work INTRODUCTION: The optimal time to discontinue patients from mechanical ventilation is critical as premature discontinuation as well as delayed weaning can result in complications. The literature on diaphragm function assessment during the weaning process in the intriguing subpopulation of critically ill neuromuscular disease patients is lacking. METHODS: Patients with neuromuscular diseases, on mechanical ventilation for more than 7 days, and who were ready for weaning were studied. During multiple T-piece trials over days, diaphragm function using ultrasound and diaphragm electrical activity (Edi peaks using NAVA catheter) was measured every 30 min till a successful 2 h weaning. RESULTS: A total of 18 patients were screened for eligibility over 5-month period and eight patients fulfilled the inclusion criteria. Sixty-three data points in these 8 subjects were available for analysis. A successful breathing trial was predicted by Edi reduction (1.22 μV for every 30 min increase in weaning duration; 0.69 μV for every day of weaning) and increase in diaphragm excursion (2.81 mm for every 30 min increase in weaning duration; 2.18 mm for every day of weaning). CONCLUSION: The Edi and diaphragm excursion changes can be used as additional objective tools in the decision-making of the weaning trials in neuromuscular disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12028-020-01141-9) contains supplementary material, which is available to authorized users. Springer US 2020-11-18 2021 /pmc/articles/PMC7673684/ /pubmed/33210265 http://dx.doi.org/10.1007/s12028-020-01141-9 Text en © Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Work
Krishnakumar, Mathangi
Muthuchellappan, Radhakrishnan
Chakrabarti, Dhritiman
Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases
title Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases
title_full Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases
title_fullStr Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases
title_full_unstemmed Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases
title_short Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases
title_sort diaphragm function assessment during spontaneous breathing trial in patients with neuromuscular diseases
topic Original Work
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673684/
https://www.ncbi.nlm.nih.gov/pubmed/33210265
http://dx.doi.org/10.1007/s12028-020-01141-9
work_keys_str_mv AT krishnakumarmathangi diaphragmfunctionassessmentduringspontaneousbreathingtrialinpatientswithneuromusculardiseases
AT muthuchellappanradhakrishnan diaphragmfunctionassessmentduringspontaneousbreathingtrialinpatientswithneuromusculardiseases
AT chakrabartidhritiman diaphragmfunctionassessmentduringspontaneousbreathingtrialinpatientswithneuromusculardiseases